Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 (PPARγ-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population

AbstractClin Chem Lab Med 2007;45:477–82.

Aleglitazar, a dual peroxisome proliferator-activated receptor-α/γ agonist, improves insulin sensitivity, glucose control and lipid levels in people with type 2 diabetes: findings from a randomized, double-blind trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12620 ◽

2016 ◽

Vol 18 (7) ◽

pp. 711-715 ◽

Cited By ~ 9

Author(s):

A. O. Stirban ◽

M. Andjelkovic ◽

T. Heise ◽

L. Nosek ◽

A. Fischer ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Sensitivity ◽

Glucose Control ◽

Peroxisome Proliferator ◽

Double Blind Trial ◽

Lipid Levels ◽

Double Blind ◽

Blind Trial

Peroxisome proliferator-activated receptor-??Pro12Ala polymorphism and the association with blood pressure in type 2 diabetes

Journal of Hypertension ◽

10.1097/00004872-200309000-00014 ◽

2003 ◽

Vol 21 (9) ◽

pp. 1657-1662 ◽

Cited By ~ 42

Author(s):

Carl J ??stgren ◽

Ulf Lindblad ◽

Olle Melander ◽

Arne Melander ◽

Leif Groop ◽

...

Keyword(s):

Blood Pressure ◽

Type 2 Diabetes ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

The Human Peroxisome Proliferator-Activated Receptor 2 (PPAR 2) Pro12Ala Polymorphism Is Associated With Decreased Risk of Diabetic Nephropathy in Patients With Type 2 Diabetes

Diabetes ◽

10.2337/diabetes.52.12.3010 ◽

2003 ◽

Vol 52 (12) ◽

pp. 3010-3013 ◽

Cited By ~ 54

Author(s):

M. L. Caramori ◽

L. H. Canani ◽

L. A. Costa ◽

J. L. Gross

Keyword(s):

Type 2 Diabetes ◽

Diabetic Nephropathy ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor γ2 gene on rosiglitazone response in type 2 diabetes

Clinical Pharmacology & Therapeutics ◽

10.1016/j.clpt.2005.04.013 ◽

2005 ◽

Vol 78 (2) ◽

pp. 202-208 ◽

Cited By ~ 80

Author(s):

E KANG ◽

S PARK ◽

H KIM ◽

C KIM ◽

C AHN ◽

...

Keyword(s):

Type 2 Diabetes ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

Γ2 Gene

The peroxisome proliferator-activated receptor alpha agonist fenofibrate has no effect on insulin sensitivity compared to atorvastatin in type 2 diabetes mellitus; a randomised, double-blind controlled trial

Journal of Diabetes and its Complications ◽

10.1016/j.jdiacomp.2014.01.001 ◽

2014 ◽

Vol 28 (3) ◽

pp. 323-327 ◽

Cited By ~ 15

Author(s):

R. Neil A. Black ◽

Cieran N. Ennis ◽

Ian S. Young ◽

Steven J. Hunter ◽

A. Brew Atkinson ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Sensitivity ◽

Controlled Trial ◽

Peroxisome Proliferator ◽

Double Blind ◽

Alpha Agonist

Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARγ2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population

Biochemical Genetics ◽

10.1007/s10528-016-9765-6 ◽

2016 ◽

Vol 55 (1) ◽

pp. 10-21 ◽

Cited By ~ 9

Author(s):

Misbah Majid ◽

Akbar Masood ◽

Showkat Ahmad Kadla ◽

Iqra Hameed ◽

Bashir A. Ganai

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

Kashmiri Population

An analysis of peroxisome proliferator-activated receptor gamma (PPAR-γ2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2006.12.007 ◽

2007 ◽

Vol 17 (9) ◽

pp. 632-641 ◽

Cited By ~ 27

Author(s):

R. Scacchi ◽

A. Pinto ◽

O. Rickards ◽

A. Pacella ◽

G.F. De Stefano ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Dietary Habits ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ 2 (PPARγ 2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2002-23487 ◽

2002 ◽

Vol 110 (02) ◽

pp. 60-66 ◽

Cited By ~ 27

Author(s):

B. Zietz ◽

N. Barth ◽

D. Spiegel ◽

G. Schmitz ◽

J. Schölmerich ◽

...

Keyword(s):

Type 2 Diabetes ◽

Total Cholesterol ◽

Ldl Cholesterol ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

Diabetes Patients

Peroxisome proliferator-activated receptor-γ2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes

Neuroscience Letters ◽

10.1016/j.neulet.2006.08.024 ◽

2006 ◽

Vol 410 (2) ◽

pp. 141-145 ◽

Cited By ~ 16

Author(s):

Byung Cheol Lee ◽

Hye-jung Lee ◽

Joo-Ho Chung

Keyword(s):

Type 2 Diabetes ◽

Ischemic Stroke ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽

Reduced Risk

P17 No Association between Pro12Ala polymorphism in Peroxisome Proliferator Activated Receptor Gamma 2 gene and type 2 diabetes in a Cameroonian population

Diabetes Research and Clinical Practice ◽

10.1016/s0168-8227(14)70125-1 ◽

2014 ◽

Vol 103 ◽

pp. S37-S38

Author(s):

E.P. Mofo Mato ◽

E. Sobngwi ◽

O. Donfack Sontsa ◽

E.N. Ndonwi ◽

M. Guewo Fokeng ◽

...

Keyword(s):

Type 2 Diabetes ◽

Peroxisome Proliferator ◽

Pro12ala Polymorphism ◽